Management of hepatic schistosomiasis.
D000208:Acute Disease; D000818:Animals; D002490:Central Nervous System / Q000473:pathology; D002648:Child; D002908:Chronic Disease; D003106:Colon / Q000473:pathology; D003937:Diagnosis, Differential; D006525:Hepatitis, Viral, Human / Q000150:complications; D006801:Humans; D006975:Hypertension, Portal / Q000188:drug therapy / Q000601:surgery / Q000628:therapy; D007668:Kidney / Q000473:pathology; D008099:Liver / Q000000981:diagnostic imaging / Q000473:pathology; D008109:Liver Diseases, Parasitic / Q000150:complications / Q000276:immunology / Q000473:pathology / Q000628:therapy; D051379:Mice; D009560:Niridazole / Q000627:therapeutic use; D010073:Oxamniquine / Q000627:therapeutic use; D011223:Praziquantel / Q000627:therapeutic use; D011859:Radiography; D012480:Salmonella Infections / Q000150:complications; D012552:Schistosomiasis / Q000150:complications / Q000276:immunology / Q000473:pathology / Q000628:therapy; D012556:Schistosomicides / Q000627:therapeutic use; D012597:Sclerosing Solutions / Q000627:therapeutic use
D012556:Schistosomicides; D012597:Sclerosing Solutions; D010073:Oxamniquine; D011223:Praziquantel; D009560:Niridazole